MetLife, Inc. $MET Shares Acquired by Kestra Advisory Services LLC

Posted by George Bondi on Nov 12th, 2026

Kestra Advisory Services LLC lifted its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 14.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 65,008 shares of the financial services provider’s stock after purchasing an additional 7,993 shares during the quarter. Kestra Advisory Services LLC’s holdings in MetLife were worth $6,121,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. CX Institutional lifted its position in MetLife by 1.3% during the third quarter. CX Institutional now owns 8,672 shares of the financial services provider’s stock valued at $817,000 after buying an additional 115 shares in the last quarter. Investment Research Partners LLC increased its position in shares of MetLife by 3.9% in the third quarter. Investment Research Partners LLC now owns 3,103 shares of the financial services provider’s stock worth $292,000 after acquiring an additional 116 shares in the last quarter. McGlone Suttner Wealth Management Inc. raised its stake in shares of MetLife by 0.6% in the 3rd quarter. McGlone Suttner Wealth Management Inc. now owns 22,391 shares of the financial services provider’s stock valued at $2,108,000 after acquiring an additional 124 shares during the period. Capital Analysts LLC raised its stake in shares of MetLife by 0.3% in the 2nd quarter. Capital Analysts LLC now owns 38,262 shares of the financial services provider’s stock valued at $3,238,000 after acquiring an additional 129 shares during the period. Finally, Carnegie Investment Counsel lifted its holdings in shares of MetLife by 4.4% during the 3rd quarter. Carnegie Investment Counsel now owns 3,136 shares of the financial services provider’s stock valued at $295,000 after acquiring an additional 132 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

NYSE:MET opened at $102.97 on Thursday. The firm has a 50-day moving average of $98.57 and a two-hundred day moving average of $86.65. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.21 and a quick ratio of 0.20. The stock has a market cap of $64.71 billion, a P/E ratio of 13.43, a PEG ratio of 0.97 and a beta of 0.79. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $106.72.

MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, beating analysts’ consensus estimates of $2.77 by $0.01. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The firm had revenue of $20.52 billion during the quarter, compared to analyst estimates of $19.86 billion. During the same quarter last year, the firm earned $2.34 EPS. MetLife’s quarterly revenue was up 18.2% on a year-over-year basis. On average, research analysts expect that MetLife, Inc. will post 9.94 earnings per share for the current fiscal year.

MetLife announced that its board has initiated a stock repurchase plan on Wednesday, August 5th that authorizes the company to buy back $3 billion in shares. This repurchase authorization authorizes the financial services provider to purchase up to 4.8% of its shares through open market purchases. Share repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, November 3rd. MetLife’s payout ratio is 30.90%.

Wall Street Analysts Forecast Growth

MET has been the subject of a number of research reports. Keefe, Bruyette & Woods upped their price target on shares of MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Piper Sandler raised their price objective on MetLife from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday. Atlantic Securities set a $103.00 price objective on MetLife in a research report on Wednesday, July 15th. Mizuho set a $112.00 price objective on MetLife in a research note on Monday. Finally, Weiss Ratings raised MetLife from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $106.62.

Check Out Our Latest Report on MetLife

MetLife Profile

(Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.